-
公开(公告)号:US20190241612A1
公开(公告)日:2019-08-08
申请号:US16383016
申请日:2019-04-12
Applicant: University of Kansas
Inventor: Jane V. Aldrich , S P Sanjeewa Nilendra Senadheera
IPC: C07K5/12
Abstract: Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.
-
公开(公告)号:US20170190738A1
公开(公告)日:2017-07-06
申请号:US15325177
申请日:2015-07-13
Applicant: University of Kansas
Inventor: Jane V. Aldrich , S P Sanjeewa Nilendra Senadheera
IPC: C07K5/12
Abstract: Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.
-
公开(公告)号:US10259843B2
公开(公告)日:2019-04-16
申请号:US15325177
申请日:2015-07-13
Applicant: University of Kansas
Inventor: Jane V. Aldrich , S P Sanjeewa Nilendra Senadheera
Abstract: Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.
-
公开(公告)号:US10988506B2
公开(公告)日:2021-04-27
申请号:US16383016
申请日:2019-04-12
Applicant: University of Kansas
Inventor: Jane V. Aldrich , S P Sanjeewa Nilendra Senadheera
Abstract: Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.
-
-
-